Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3753K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Svensson, C. I. Articles by Serhan, C. N. Search for Related Content PubMed PubMed Citation Articles by Svensson, C. I. Articles by Serhan, C. N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETYLSALICYLIC ACID CARRAGEENAN GUM Medline Plus Health Information Pain Related Collections Related Article Social Bookmarking                      What's this?

¹ Department of Anesthesiology, University of California, San Diego, La Jolla, CA 92093
² Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
³ Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, Boston, MA 02115

CORRESPONDENCE Camilla I. Svensson: csvensson{at}ucsd.edu OR Charles N. Serhan: cnserhan{at}zeus.bwh.harvard.edu

Inflammatory conditions can lead to debilitating and persistent pain. This hyperalgesia reflects sensitization of peripheral terminals and facilitation of pain signaling at the spinal level. Studies of peripheral systems show that tissue injury triggers not only inflammation but also a well-orchestrated series of events that leads to reversal of the inflammatory state. In this regard, lipoxins represent a unique class of lipid mediators that promote resolution of inflammation. The antiinflammatory role of peripheral lipoxins raises the hypothesis that similar neuraxial systems may also down-regulate injury-induced spinal facilitation of pain processing. We report that the lipoxin A₄ receptor is expressed on spinal astrocytes both in vivo and in vitro and that spinal delivery of lipoxin A₄, as well as stable analogues, attenuates inflammation-induced pain. Furthermore, activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase in astrocytes, which has been indicated to play an important role in spinal pain processing, was attenuated in the presence of lipoxins. This linkage opens the possibility that lipoxins regulate spinal nociceptive processing though their actions upon astrocytic activation. Targeting mechanisms that counterregulate the spinal consequences of persistent peripheral inflammation provide a novel endogenous mechanism by which chronic pain may be controlled.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

• Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., Murphy, P. M. (2009). International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family. Pharmacol. Rev. 61: 119-161 [Abstract] [Full Text]  
• Decker, Y., McBean, G., Godson, C. (2009). Lipoxin A4 inhibits IL-1{beta}-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. Am. J. Physiol. Cell Physiol. 296: C1420-C1427 [Abstract] [Full Text]  
• Dangi, B., Obeng, M., Nauroth, J. M., Teymourlouei, M., Needham, M., Raman, K., Arterburn, L. M. (2009). Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6). J. Biol. Chem. 284: 14744-14759 [Abstract] [Full Text]  
• Sobrado, M., Pereira, M. P., Ballesteros, I., Hurtado, O., Fernandez-Lopez, D., Pradillo, J. M., Caso, J. R., Vivancos, J., Nombela, F., Serena, J., Lizasoain, I., Moro, M. A. (2009). Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPAR{gamma}-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke. J. Neurosci. 29: 3875-3884 [Abstract] [Full Text]  
• Medeiros, R., Rodrigues, G. B., Figueiredo, C. P., Rodrigues, E. B., Grumman, A. Jr., Menezes-de-Lima, O. Jr., Passos, G. F., Calixto, J. B. (2008). Molecular Mechanisms of Topical Anti-Inflammatory Effects of Lipoxin A4 in Endotoxin-Induced Uveitis. Mol. Pharmacol. 74: 154-161 [Abstract] [Full Text]  
• Levy, B. D., Lukacs, N. W., Berlin, A. A., Schmidt, B., Guilford, W. J., Serhan, C. N., Parkinson, J. F. (2007). Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism. FASEB J. 21: 3877-3884 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS